CHDR Research Opportunities The Center for Human Development research is currently recruiting participants for the following research studies: LUMINENZ-AT (CM-AT) in Autism We are evaluating the safety and effectiveness of an investigational medication designed to treat the symptoms of autism in children. Children between the ages of 3-8 years with autism may be eligible to participate in this 12-week, placebo-controlled trial, where half of the participants will receive the investigational medication and half will receive placebo. This study involves 6 visits (each visit ranging from 2-5 hours) to the clinic. During the initial visit, the child will undergo a free psychological screening evaluation of their IQ, language, and symptoms of autism and physical examination. The subsequent visits will be measures of behavior and medical check-ups to monitor the progress on the medication. For more information or to be screened, call Rosleen Mansour at 713-486-2591 or email Rosleen Mansour@uth.tmc.edu
We are currently recruiting children and adolescents with Autism Spectrum Disorders . This study will examine the cognitive and behavioral symptoms of children who have Autism Spectrum Disorders or ADHD and the effectiveness of methylphenidate in treating attention and behavior problems in children who have both Autism and ADHD symptoms. Click here for more information. Participants may also join our Research Registry and we will contact them for future studies. You may join by: Home
| News | Mission | Faculty
| Staff | Labs | Current
Research | Research Opportunities Contact Rosleen.Mansour@uth.tmc.edu
with comments or suggestions |